Galera Therapeutics, Inc. (GRTX)
OTCMKTS · Delayed Price · Currency is USD
0.0897
+0.0035 (4.06%)
Apr 16, 2026, 10:18 AM EST
Galera Therapeutics Employees
Galera Therapeutics had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
$21,174,667
Market Cap
6.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | -4 | -57.14% |
| Dec 31, 2023 | 7 | -24 | -77.42% |
| Dec 31, 2022 | 31 | 1 | 3.33% |
| Dec 31, 2021 | 30 | -8 | -21.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Orgenesis | 77 |
| NKGen Biotech | 26 |
| Mosaic ImmunoEngineering | 8 |
| Bioxytran | 3 |
| AccuStem Sciences | 2 |
| Synlogic | 1 |
Galera Therapeutics News
- 1 day ago - Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement - GlobeNewsWire
- 2 days ago - Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement - Business Wire
- 6 months ago - Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million - GlobeNewsWire
- 1 year ago - Galera Therapeutics completes acquisition of Nova Pharmaceuticals - GlobeNewsWire
- 1 year ago - Galera Announces Board Approval of Complete Liquidation and Dissolution - GlobeNewsWire
- 2 years ago - Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 2 years ago - Galera Adopts Limited Duration Stockholder Rights Agreement - GlobeNewsWire
- 2 years ago - Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates - GlobeNewsWire